Cargando…
Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening
One therapeutic approach to Duchenne Muscular Dystrophy (DMD) recently entering clinical trials aims to convert DMD phenotypes to that of a milder disease variant, Becker Muscular Dystrophy (BMD), by employing antisense oligonucleotides (AONs) targeting splice sites, to induce exon skipping and rest...
Autores principales: | O'Leary, Debra A., Sharif, Orzala, Anderson, Paul, Tu, Buu, Welch, Genevieve, Zhou, Yingyao, Caldwell, Jeremy S., Engels, Ingo H., Brinker, Achim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791862/ https://www.ncbi.nlm.nih.gov/pubmed/20020055 http://dx.doi.org/10.1371/journal.pone.0008348 |
Ejemplares similares
-
Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
por: Greer, Kane L, et al.
Publicado: (2014) -
HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1
por: O’Leary, Debra A., et al.
Publicado: (2010) -
Multiple exon skipping strategies to by-pass dystrophin mutations
por: Adkin, Carl F., et al.
Publicado: (2012) -
Elusive sources of variability of dystrophin rescue by exon skipping
por: Vila, Maria Candida, et al.
Publicado: (2015) -
AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation
por: Gerard, Xavier, et al.
Publicado: (2012)